Ramirez Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Sell
2,984
-1
-0% -$480 0.16% 121
2026
Q1
$1.47M Sell
2,985
-114
-4% -$61.9K 0.18% 120
2025
Q4
$1.8M Hold
3,099
0.24% 116
2025
Q3
$1.5M Buy
3,099
+834
+37% +$388K 0.21% 122
2025
Q2
$918K Hold
2,265
0.14% 144
2025
Q1
$1.13M Buy
2,265
+4
+0.2% +$2.17K 0.23% 119
2024
Q4
$1.18M Hold
2,261
0.24% 117
2024
Q3
$1.4M Hold
2,261
0.27% 104
2024
Q2
$1.25M Hold
2,261
0.25% 109
2024
Q1
$1.31M Hold
2,261
0.27% 111
2023
Q4
$1.2M Buy
2,261
+25
+1% +$12.1K 0.24% 117
2023
Q3
$1.13M Buy
+2,236
New +$1.19M 0.24% 119

Other funds holding TMO

Ramirez Asset Management's TMO Position: Q2 2026 in Review

Ramirez Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 0.03% in Q2 2026, selling an estimated $480 and leaving 2,984 shares worth $1.5M. The position accounts for 0.16% of the portfolio, ranked #121.

Ramirez Asset Management first reported a position in TMO in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.8M in Q4 2025. 2,617 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ramirez Asset Management held 2,984 shares of Thermo Fisher Scientific worth $1.5M as of Q2 2026.
  • Ramirez Asset Management sold 1 Thermo Fisher Scientific share in Q2 2026, an estimated $480.
  • Thermo Fisher Scientific made up 0.16% of Ramirez Asset Management's portfolio in Q2 2026, its #121 holding.
  • Ramirez Asset Management first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 12 quarters since.
  • Ramirez Asset Management's Thermo Fisher Scientific position peaked at $1.8M in Q4 2025.
  • 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ramirez Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.